Artwork

Content provided by Johns Hopkins Kimmel Cancer Center. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Johns Hopkins Kimmel Cancer Center or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Cancer Matters with Dr Bill Nelson - FDA Approval of a Drug Targeting a Brain Cancer Mutation

13:17
 
Distribuie
 

Manage episode 433007019 series 2310018
Content provided by Johns Hopkins Kimmel Cancer Center. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Johns Hopkins Kimmel Cancer Center or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Dr Bill Nelson talks with Dr Matthias Holdhoff about the treatment of brain cancer and a significant FDA approval of a new drug treatment for a type of brain cancer, called low-grade glioma. The drug, called vorasidenib, is a targeted cancer therapy that works by inhibiting the activity of a mutated gene called IDH, slowing the growth of the cancer. Read more here

  continue reading

120 episoade

Artwork
iconDistribuie
 
Manage episode 433007019 series 2310018
Content provided by Johns Hopkins Kimmel Cancer Center. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Johns Hopkins Kimmel Cancer Center or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Dr Bill Nelson talks with Dr Matthias Holdhoff about the treatment of brain cancer and a significant FDA approval of a new drug treatment for a type of brain cancer, called low-grade glioma. The drug, called vorasidenib, is a targeted cancer therapy that works by inhibiting the activity of a mutated gene called IDH, slowing the growth of the cancer. Read more here

  continue reading

120 episoade

Toate episoadele

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință